Reproductive Genetic Testing
VCGS offers a comprehensive range of reproductive screening and diagnostic testing options with expert laboratory and clinical support. This means both patients and health professionals are fully supported.
percept™ non-invasive prenatal test includes assessment of all the chromosomes for identifying pregnancies at increased chance of having a chromosome condition, making it Australia's most advanced NIPT.
prepair™ is a genetic carrier screen that gives individuals and couples information about their chance of having a child with a genetic condition.
Maternal serum screening is a blood test available to pregnant women who want to know their chance of having a baby with a chromosome condition, such as Down syndrome. Serum screening can also provide additional information about pregnancy health, such as the risk of developing early-onset pre-eclampsia.
Diagnostic testing for the identification of chromosome changes that affect normal fetal development and for the investigation of genetic causes of recurrent pregnancy loss and infertility.
Biochemical Genetics
Biochemical genetics involves the diagnosis, monitoring and treatment of metabolic conditions.
Newborn bloodspot screening is an extremely successful public health program which identifies babies that may have rare but significant medical conditions.
Metabolic disorders are a group of serious medical conditions caused by abnormal levels of metabolites in the blood or urine. This can be toxic and affect normal development.
Genetics and Genomics
VCGS provides a comprehensive range of specialist adult and childhood genetic tests and clinical services. Technologies include Next Generation Sequencing, SNP chromosome microarray, Sanger sequencing and MLPA.
Our detailed phenotype-based approach provides the most effective and reliable way to identify disease-causing variants. VCGS provides Australia's most cost-effective, NATA accredited clinical genomics sequencing service.
Disorders/Differences of Sex Development (DSD)
Disorders/Differences of Sex Development (DSD) are conditions where the development of chromosomal, anatomical or gonadal sex is atypical. DSD covers a wide spectrum of disorders such as hypospadias (misplacement of the urethral opening on the penis), premature ovarian insufficiency and complete sex reversal (where the physical sex does not match the genetic sex of an individual).
Analyse key genes in one test:
Dementia, Alzheimer, Parkinson, Motor Neurone & other neurogenetic disorders
Complete sequence coverage and flexible phenotype driven panels with custom design options provide comprehensive inherited cardiac testing that is more affordable.
A chromosome microarray is a powerful tool used to look at genetic changes that affect health or development. Using high density SNP based technology allows for the identification of a larger number of genetic conditions.
spinal muscular atrophy carrier screening
This test is a genetic screen to identify if you are a carrier of spinal muscular atrophy.
You must have a completed doctors request form to order this test online.
Cost
The cost of this test is AUD$220.00. No Medicare rebate available.
Spinal muscular atrophy carrier screening is available as a single test to order and pay online.
cystic fibrosis carrier screening & diagnostic
This test is a genetic screen to identify if you are a carrier of cystic fibrosis and is available to order and pay online.
You must have a completed doctors request form to order this test.
Cost
The cost of this test is AUD$212.50.
Medicare eligibility
Patients may be eligible for a Medicare rebate, if:
Choose VCGS for comprehensive genetic testing and support services for a large range of single gene disorders including cystic fibrosis, fragile X syndrome, ataxias and hearing loss.
Mitochondria are best known for being the body's power plants. They burn the food in our diet to generate energy for our body. Mitochondrial disorders occur when they can't burn fuel properly, or when their structure is defective.
VCGS provides a comprehensive range of diagnostic genetic testing for childhood cancers and has led the development of an advanced test for monitoring bone marrow and organ transplants.